Splenomegaly Latest Advances

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Journal: Leukemia & lymphoma

Published: April 15, 2026

Clinical characteristics and complications in children and adolescents with hyperleukocytic acute leukemia.

Journal: Archivos argentinos de pediatria

Published: April 14, 2026

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

Journal: BMJ case reports

Published: April 14, 2026

PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4)P ₂ -Dependent AKT Hyperactivation.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

Journal: Expert review of clinical pharmacology

Published: April 08, 2026

A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's Thyroiditis.

Journal: Internal medicine (Tokyo, Japan)

Published: April 08, 2026

The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions

Journal: Zhonghua nei ke za zhi

Published: April 06, 2026

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Journal: Expert opinion on pharmacotherapy

Published: April 01, 2026

Primary Splenic Classic Hodgkin Lymphoma with Immune Thrombocytopenic Purpura and Extramedullary Hematopoiesis.

Journal: International journal of surgical pathology

Published: April 01, 2026

Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020-2023.

Journal: Emerging infectious diseases

Published: March 21, 2026

Indolent γδT-cell clone in Felty syndrome: a case report and literature review

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: March 16, 2026

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan.

Journal: Hemoglobin

Published: March 11, 2026

Splenomegaly Latest Advances

Find the Latest Research About Splenomegaly

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Managing myelofibrosis in the frailty era: the expanding role of JAK inhibitors.

Clinical characteristics and complications in children and adolescents with hyperleukocytic acute leukemia.

Clinical characteristics and complications in children and adolescents with hyperleukocytic acute leukemia.

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

Myeloproliferative neoplasm as a cause of splanchnic vein thrombosis.

PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4)P ₂ -Dependent AKT Hyperactivation.

PITPβ Drives JAK2 V617F-Mediated Myeloproliferative Neoplasms by Promoting PtdIns(3,4)P ₂ -Dependent AKT Hyperactivation.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

A pharmacological profile of pacritinib for the treatment of myelofibrosis.

A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's Thyroiditis.

A Case of Autoimmune Polyendocrine Syndrome Type 3C with Warm-type Autoimmune Hemolytic Anemia which Developed during Treatment for Hashimoto's Thyroiditis.

The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions

The 516th case: hyperinflammatory state, acute renal dysfunction, hepatosplenomegaly with lymphadenopathy, and recurrent cerebral infarctions

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Combination treatments for myelofibrosis in JAK inhibitor-naive patients: evidence, rationale, and clinical direction.

Primary Splenic Classic Hodgkin Lymphoma with Immune Thrombocytopenic Purpura and Extramedullary Hematopoiesis.

Primary Splenic Classic Hodgkin Lymphoma with Immune Thrombocytopenic Purpura and Extramedullary Hematopoiesis.

Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020-2023.

Indeterminant Interferon-γ Release Assays in Refugee Children with Splenomegaly, Uganda, 2020-2023.

Indolent γδT-cell clone in Felty syndrome: a case report and literature review

Indolent γδT-cell clone in Felty syndrome: a case report and literature review

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan.

Comparative Analysis of Erythroferrone and Hepcidin as Emerging Biomarkers of Iron Homeostasis in Patients with β-Thalassemia Major: A Case-Control Study from Pakistan.